Renakbiotech is at the forefront of research into the molecular mechanisms associated with acute kidney injury (AKI), chronic kidney disease (CKD) and hypertension, which are on the rise globally. Our mission is to facilitate rapid urine-based diagnosis of AKI, CKD, ESRD and hypertension with special emphasis on the black population.
